Tenofovir: all 281 studies that test it
Page 3 of 3. Open to participants first (11), then studies with results posted, then the rest; newest registration first within each.
- Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in LymphomaWithdrawnNCT01528865Phase 1/2
- Tenofovir in Chronic Hepatitis B With Mild ALT ElevationCompletedNCT01522625Phase 4
- Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B PatientsStatus unknownNCT01491295Phase 4
- Evaluating the Safety of Tenofovir Vaginal Gel in HIV-Uninfected Pregnant WomenWithdrawnNCT01490671Phase 2
- Safety, Efficacy and Dose-response Study of BMS-986001 in Subjects With HIV-1 Infection Who Are Treatment-naiveTerminatedNCT01489046Phase 2
- Pharmacokinetic (PK) Profiles of Tenofovir Disoproxil Fumarate (TDF) 300 mg in Healthy Chinese SubjectsCompletedNCT01480622Phase 1
- Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) InfectionCompletedNCT01386294Phase 3
- Pharmacokinetic and Pharmacodynamic Study of Tenofovir 1% GelCompletedNCT01369303Phase 1
- Two Clinical Trials to Evaluate Pharmacokinetics of Unboosted and Boosted Atazanavir Used Alone or Co-administered With Tenofovir DF in Healthy Korean and Caucasian Male VolunteersStatus unknownNCT01368783Phase 1
- Rollover Protocol Continued Access to Tenofovir Disoproxil Fumarate (TDF) for Subjects in TaiwanCompletedNCT01334567Phase 2
- Safety and Efficacy of Raltegravir+TDF+3TC in HBV/HIV Co-infected PatientsStatus unknownNCT01318096Not applicable
- Microbicide Safety and Acceptability in Young MenCompletedNCT01283360Phase 1
- Dose-Proportionality and Intra-Individual Variability of Intracellular TFV-DP and FTC-TP in Healthy VolunteersCompletedNCT01276600Phase 1
- Metabolic Effects of Atazanavir/Ritonavir Versus Darunavir/Ritonavir in Combination With Tenofovir/Emtricitabine in naïve HIV-1 Infected PatientsCompletedNCT01274780Phase 4
- Randomized Controlled Study of Tenofovir Plus Telbivudine Versus Monotherapy With Either Drug in HBeAg Negative Chronic Hepatitis B PatientsWithdrawnNCT01260610Not applicable
- Rectal Safety and Acceptability Study of Tenofovir 1% GelCompletedNCT01232803Phase 1
- TMC435-TiDP16-C114 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and the Antiretroviral Agents TMC278 and TenofovirCompletedNCT01205139Phase 1
- Tenofovir Gel in Pregnancy and LactationCompletedNCT01136759Phase 1
- A Study of Pegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D.CompletedNCT01088659Phase 3
- Randomized Controlled Trial of Tenofovir in Patients of Reactivation of Hepatitis B Presenting as Acute on Chronic Liver FailureCompletedNCT01074645Phase 4
- Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection StatusCompletedNCT01040091Phase 1
- Optimisation of Primary HIV1 Infection Treatment(ANRS 147 OPTIPRIM)CompletedNCT01033760Phase 3
- Appropriate Timing of HAART in Co-infected HIV/TB PatientsTerminatedNCT01014481Phase 4
- Simvastatin for the Treatment of Chronic Hepatitis BCompletedNCT00994773Phase 1
- Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral TabletCompletedNCT00984971Phase 1
- Hepatitis B Surface Antigen(HBsAg) Loss in Chronic Hepatitis B Patients With Low Viral LoadCompletedNCT00973219Not applicable
- HIDIT II - PegIFN-alfa2a Plus Tenofovir in Chronic Delta HepatitisCompletedNCT00932971Phase 2
- Examining Hair to Determine Tenofovir ExposureCompletedNCT00903084Phase 1
- Raltegravir Activity In Lymphoid TissuesWithdrawnNCT00863668Not applicable
- Effects of 2 Initial Standard Antiretroviral Combinations Therapies on Lipid MetabolismStatus unknownNCT00759070Phase 4
- GSK1349572 Drug Interaction With TenofovirCompletedNCT00726336Phase 1
- A Single-arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without add-on Tenofovir in Adults With HBeAg-positive Chronic Hepatitis B (CHB)CompletedNCT00651209Phase 4
- Metabolic Impact Assessment of Tenofovir Disoproxil Fumarate on Non-HIV-1 Infected Healthy Adult Male VolunteersCompletedNCT00648817Phase 4
- Study to Evaluate Changes in Limb Fat When Switching From a Thymidine AnalogueCompletedNCT00647946Phase 2
- Efficacy and Safety of Switching From Retrovir to Tenofovir or Abacavir in HIV-infected PatientsCompletedNCT00647244Phase 4
- Interventional Study of Mucosal and Antimicrobial Responses to Repeated Vaginal Applications of Tenofovir Gel in HIV Uninfected WomenCompletedNCT00594373Phase 1
- Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA)CompletedNCT00573001Phase 3
- Pharmacokinetic Study of the Vaginal Microbicide Agent 1% Tenofovir GelCompletedNCT00561496Phase 1
- Comparison of Epzicom and Truvada for the Initial Once Daily HIV TreatmentCompletedNCT00544128Phase 4
- Blood Levels of Tenofovir Gel in HIV Uninfected Pregnant Women Planning Cesarean DeliveryCompletedNCT00540605Phase 1
- Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/MclCompletedNCT00532168Phase 4
- Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and TruvadaCompletedNCT00528060Phase 2
- Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With TuberculosisStatus unknownNCT00474435Phase 2
- Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention of HIVCompletedNCT00441298Phase 2
- Trial of Telbivudine Combination Therapy vs. Continued Adefovir MonotherapyWithdrawnNCT00409019Phase 4
- Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated With Lopinavir or Efavirenz.TerminatedNCT00386659Phase 4
- Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected PatientsCompletedNCT00365612Phase 4
- Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/TenofovirCompletedNCT00365339Phase 1
- Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV Co-infected PatientsCompletedNCT00358696Phase 4
- Safety and Durability ofTenofovir and a Cell Cycle Agent for Viral SuppressionCompletedNCT00344981Not applicable
- Tenofovir/Emtricitabine for PMTCT in Africa and Asia (ANRS 12109 TEmAA)CompletedNCT00334256Phase 2
- Safety Study of Once a Day ART and Opiate Substitute.CompletedNCT00324688Phase 4
- Tenofovir in HIV/HBV CoinfectionCompletedNCT00192595Phase 4
- Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.CompletedNCT00158821Phase 3
- Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207)CompletedNCT00158457Phase 3
- Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-InfectionCompletedNCT00127959Phase 4
- Efficacy and Safety of Tenofovir DF/Atazanavir Enhanced With Low Dose of Ritonavir in HIV-Infected PatientsTerminatedNCT00122577Phase 2
- Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIVTerminatedNCT00122512Phase 2
- Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIVCompletedNCT00122486Phase 2
- Safety and Blood Levels of Tenofovir Disoproxil Fumarate in HIV Infected Pregnant Women and Their BabiesCompletedNCT00120471Phase 1
- Safety and Acceptability of a Vaginal MicrobicideCompletedNCT00111943Phase 2
- Botswana Tenofovir Oral HIV Prophylaxis TrialTerminatedNCT00111150Phase 2/3
- Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug TherapyCompletedNCT00109603Not applicable
- Tenofovir DF (Disoproxil Fumarate) in Combination With Emtricitabine in HIV-1 PatientsCompletedNCT00106379Phase 4
- Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in CambodiaWithdrawnNCT00078182Phase 2/3
- Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their InfantsCompletedNCT00076791Phase 1
- A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior TherapyCompletedNCT00053638Phase 3
- Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic FailureCompletedNCT00038506Phase 4
- Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovir DF in HIV-Infected PatientsCompletedNCT00038220Phase 2
- A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIVCompletedNCT00033163Phase 2
- Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected PeopleCompletedNCT00028366Not applicable
- Safety and Acceptability of the Anti-Microbe Vaginal Gel, PMPA GelCompletedNCT00028132Phase 1
- Tenofovir Disoproxil Fumarate to Treat Pediatric HIVCompletedNCT00024986Phase 1
- Tenofovir Disoproxil Fumarate (TDF) in HIV-1 Patients Who Have Never Taken Anti-HIV DrugsCompletedNCT00016588Not applicable
- Tenofovir Disoproxil Fumarate in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drug CombinationsStatus unknownNCT00011089Not applicable
- The Safety of Tenofovir Disoproxil Fumarate Taken With Other Anti-HIV Drugs to Treat HIV-Infected PatientsStatus unknownNCT00007436Phase 3
- A Compassionate Use Study of Tenofovir Disoproxil Fumarate as Treatment for HIV InfectionCompletedNCT00002453Not applicable
- Safety and Effectiveness of Tenofovir Disoproxil Fumarate (Tenofovir DF) Plus Other Anti-HIV Drugs in HIV-Infected PatientsCompletedNCT00002450Phase 3
- Safety and Effectiveness of Adding PMPA Prodrug to an Anti-HIV Drug Combination to Treat HIV-Infected PatientsCompletedNCT00002415Phase 2
- The Safety and Effectiveness of PMPA Prodrug in HIV-Infected PatientsStatus unknownNCT00002396Phase 1
- A Study of PMPA in HIV-Infected PatientsCompletedNCT00002180Phase 1